Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
Venclexta fails to meet primary endpoint in multiple myeloma trial
AbbVie and Roche, pioneers in the field of leukemia treatments with Venclexta, faced a setback as their hopes to expand ...
Eli Lilly settles Whistleblower lawsuit over alleged quality issues
Settlement talks have been underway between pharmaceutical giant Eli Lilly and a former human resources officer, Amrit Mula, who blew ...
PTC cuts jobs as Europe withdraws approval for its DMD drug
PTC Therapeutics has announced an expansion of its previously planned workforce reductions as European regulatory concerns cast a shadow over ...
Adlai revives Novartis’ abandoned cancer drug, raises $57.5M in IPO to fund phase 3 trial
Adlai Nortye has solidified its financial footing, paving the way to determine the fate of its strategic investment in an ...
Abbott study shows FreeStyle Libre CGM and GLP-1 therapy improve diabetes outcomes
In the realm of diabetes management, a symbiotic relationship appears to be flourishing between Continuous Glucose Monitoring (CGM) technology and ...
ModeX secures $168M from BARDA to develop antiviral drugs for pandemic threats
In yet another remarkable development in the world of biotech, ModeX Therapeutics, in partnership with Merck, has secured a substantial ...
Structure posts promising results for oral obesity drug, but delays further data due to error
Structure Therapeutics has offered an initial glimpse into the effectiveness of its oral GLP-1 receptor agonist, reporting a notable 5% ...
AstraZeneca fined for misleading Symbicort ads that endangered patients’ health
In a startling turn of events, AstraZeneca finds itself entangled in a web of controversy as it faces stern scrutiny ...
Harbinger Health raises $140M to launch its blood-based cancer screening platform
Harbinger Health has secured substantial funding through a series B financing round, raising a total of $140 million to advance ...
Karuna submits KarXT, a novel schizophrenia drug, to FDA for approval
Karuna Pharmaceuticals has taken a significant step towards gaining approval for its schizophrenia drug, KarXT, as it formally submitted its ...
J&J’s Rybrevant combination therapy beats AZ’s Tagrisso in lung cancer trial
In a highly anticipated head-to-head battle between Johnson & Johnson’s combination therapy and AstraZeneca’s Tagrisso as a first-line treatment for ...
Merck KGaA expands AI partnership with Quris to predict drug toxicity
Merck KGaA continues to embrace the realm of artificial intelligence (AI), with a fresh development in its collaboration with Quris-AI. ...
Bluebird partners with Lonza to increase production of its gene therapies for rare diseases
As bluebird bio takes flight with its high-priced gene therapies, the company is enhancing its manufacturing capabilities through a strategic ...
Arcutis hires Incyte’s former CCO to lead commercialization of Zoryve and pipeline products
Arcutis Biotherapeutics, riding high on a dermatology approval and another on the horizon, has enlisted L. Todd Edwards as its ...
Bionomics’ PTSD drug shows positive results in phase 2 trial, boosting its share price
Bionomics is making a remarkable resurgence following a significant setback caused by the failure of an anxiety trial, with investors ...
BARDA grants $433M to Gritstone for mRNA COVID-19 vaccine trial
Gritstone Bio has been selected as the latest participant in the Biomedical Advanced Research and Development Authority’s (BARDA) Project NextGen, ...
Clario and CellCarta join forces to improve tissue and sample management in clinical trials
Clinical trial technology firm Clario has embarked on a strategic partnership with CellCarta to revolutionize the management of tissue and ...
Pharma’s digital content lacks credibility among HCPs, survey reveals
A recent survey targeting healthcare professionals (HCPs) has unveiled a striking lack of trust in digital content originating from pharmaceutical ...
GSK aims to boost HIV sales to £7B with new drugs and launches
GSK is charting an optimistic course for its HIV business, buoyed by the success of its long-acting antiretroviral therapy, Cabenuva. ...
Big Pharma agrees to negotiate drug prices with Medicare: What does it mean for patients and taxpayers?
Following the recent disclosure by the Centers for Medicare & Medicaid Services (CMS) regarding the list of drugs slated for ...
Deep Genomics unveils BigRNA, a powerful AI model for RNA biology and therapeutics
Deep Genomics is blending two groundbreaking technologies, artificial intelligence (AI) and RNA research, to explore the intricate world of RNA ...
First Patient Receives BCI-Enabled Neurostimulator to Restore Arm Function
Dutch medical device manufacturer Onward Medical has pioneered a groundbreaking approach to restoring arm and hand mobility in individuals who ...
Hermes Pharma invests in user-friendly oral dosage forms production
Hermes Pharma, a German Contract Development and Manufacturing Organization (CDMO), has announced a significant investment of 25 million euros ($26 ...
Lilly secures Emgality’s future after judge invalidates Teva’s patents
A federal judge in Massachusetts has ruled in favor of Eli Lilly, overturning a $176.5 million jury verdict issued in ...
Viatris and Ocuphire’s Ryzumvi gets FDA approval for reversing eye dilation
Viatris has achieved a significant milestone in its pursuit of reaching $1 billion in eye care sales by 2028. The ...
Big Pharma’s stance on CMS drug price negotiations remains unclear
Following the release of the list of drugs slated for pricing negotiations under the Inflation Reduction Act (IRA) by the ...
NICE rejects Enhertu for HER2-low breast cancer over cost concerns
The remarkable efficacy data that initially earned AstraZeneca and Daiichi Sankyo’s Enhertu a standing ovation at the ASCO meeting last ...
Evommune abandons EVO101, a topical IRAK4 inhibitor, for atopic dermatitis
Evommune, a California-based biotech company, has made the strategic decision to discontinue its sole clinical-stage asset, EVO101, following a thorough ...
Pfizer Collaborates with Ginkgo in a $331 Million Biobucks Partnership
Ginkgo Bioworks has secured a substantial partnership with pharmaceutical giant Pfizer, marking a significant milestone in its portfolio of collaborations. ...
AbbVie drops Caribou’s CRISPR-edited CAR-T therapies after failed trials
AbbVie has chosen to end its partnership with Caribou Biosciences, signaling a significant shift in its strategic focus. This decision ...
